메뉴 건너뛰기
American Journal of Gastroenterology
Volumn 103, Issue 1, 2008, Pages 251-252
"Ecologic niche" therapy for Crohn's disease with adjunctive rifaximin antibiotic treatment followed by Flora-Q probiotic maintenance therapy [13]
Author keywords

[No Author keywords available]
Indexed keywords

BALSALAZIDE; FLORA Q; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PROBIOTIC AGENT; RIFAXIMIN; UNCLASSIFIED DRUG;
EID: 37849015933     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01562_13.x     Document Type: Letter
Times cited : (8)
References (6)
  • 1
    • 34247243350 scopus 로고    scopus 로고
    • Bacteria in Crohn's disease: Mechanisms of inflammation and therapeutic implications
    • Sartor RB. Bacteria in Crohn's disease: Mechanisms of inflammation and therapeutic implications. J Clin Gastroenterol 2007 41 (Suppl 1 S37 43.
    • (2007) J Clin Gastroenterol , vol.41 , Issue.1
    • Sartor, R.B.1
  • 2
    • 33644553142 scopus 로고    scopus 로고
    • Antimicrobials in the management of inflammatory bowel disease
    • Gionchetti P, Rizzello F, Lammers KM, et al. Antimicrobials in the management of inflammatory bowel disease. Digestion 2006 73 (Suppl 1 77 85.
    • (2006) Digestion , vol.73 , Issue.1 , pp. 77-85
    • Gionchetti, P.1    Rizzello, F.2    Lammers, K.M.3
  • 3
    • 33646884826 scopus 로고    scopus 로고
    • Antibiotic treatment of Crohn's disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin
    • Prantera C, Lochs H, Campieri M, et al. Antibiotic treatment of Crohn's disease: Results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin. Aliment Pharmacol Ther 2006 23 : 1117 25.
    • (2006) Aliment Pharmacol Ther , vol.23 , pp. 1117-25
    • Prantera, C.1    Lochs, H.2    Campieri, M.3
  • 4
    • 23744444350 scopus 로고    scopus 로고
    • An open-label evaluation of rifaximin in the treatment of active Crohn's disease
    • Shafran I, Johnson LK. An open-label evaluation of rifaximin in the treatment of active Crohn's disease. Curr Med Res Opin 2005 21 : 1165 9.
    • (2005) Curr Med Res Opin , vol.21 , pp. 1165-9
    • Shafran, I.1    Johnson, L.K.2
  • 5
    • 0033592203 scopus 로고    scopus 로고
    • Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial
    • Rembacken BJ, Snelling AM, Hawkey PM, et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: A randomised trial. Lancet 1999 354 : 635 9.
    • (1999) Lancet , vol.354 , pp. 635-9
    • Rembacken, B.J.1    Snelling, A.M.2    Hawkey, P.M.3
  • 6
    • 0033870413 scopus 로고    scopus 로고
    • Saccharomyces boulardii in maintenance treatment of Crohn's disease
    • Guslandi M, Mezzi G, Sorghi M, et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 2000 45 : 1462 4.
    • (2000) Dig Dis Sci , vol.45 , pp. 1462-4
    • Guslandi, M.1    Mezzi, G.2    Sorghi, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.